Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01401621
Other study ID # 813606-1
Secondary ID
Status Completed
Phase N/A
First received July 21, 2011
Last updated October 8, 2015
Start date July 2014
Est. completion date December 2014

Study information

Verified date September 2015
Source University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The goal of this project is to determine whether prompting the recipient of a health reminder mailing to scratch off targeted area.


Description:

The investigators will randomly assign individuals with different scratch off messages to 3 groups. The investigators are interested in whether the scratch off message will result in an increase in compliance with the recommended health behavior.


Recruitment information / eligibility

Status Completed
Enrollment 84953
Est. completion date December 2014
Est. primary completion date October 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Indications according to Spring 2011 CDC criteria for a blood pressure check

- Indications according to Spring 2011 CDC criteria for a cholesterol test

- Employee at partner corporation that implemented the study

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
Scratchoff Prompt: Name of Test
A prompt will have the recipient scratch off the message that reveals the name of the test that the recipient needs
Scratchoff Prompt: Call to Action
A prompt will have the recipient scratch off the message to find out how to follow the recommendation that the test be received.
Control
No scratch-off element

Locations

Country Name City State
United States University of Pennsylvania Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants that schedule an appointment for receipt of the relevant test up to 52 weeks No